Home » Newsletters » BioWorld Science

BioWorld Science

June 3, 1999

View Archived Issues

Oncolytics Biotech enters reovirus development agreement

Chiroscience announces discovery of novel bone gene

Company Profile: FGene

Phase II HCV trial of Maxamine Therapy initiated

Sepracor and UCB reach Zyrtec isomer licensing agreement

Company Profile: GenoPlex

Squalene synthase inhibitor BMS-184494 tested in humans; spotlight on squalene synthase inhibitors

Plant-based Novogen product increases HDL cholesterol

Suppression of NF-kappaB enhances antitumor activity of TNF-alpha and CPT-11 via increased apoptosis

Sonata launched in Germany

Licensing opportunity from Cornell Research Foundation: antidiabetic fagopyritols

Journal alert: neostigmine is effective in the treatment of acute colonic pseudo-obstruction

Merck researchers discover nonpeptide GnRH antagonist series

DGI BioTechnologies and Novo Nordisk sign collaboration

Anti-MRSA trinems designed at Merck & Co.

Ketone-based hematopoietic agents developed at Toray

Warner-Lambert synthesizes antibacterial substituted quinazoline-2,4-diones

Novel growth factor from GDNF-neurturin family identified by Washington U. researchers

Academic investigators describe new agent for BNCT

Preclinical study indicates potential of OGT-918 in treating complicated metabolic disorders

New PDE4 inhibitors with reduced emetogenic potential in the Kyowa Hakko pipeline

Beta agonist KUL-1248, a novel agent for facilitating stone discharge and suppressing colic

Roche exercises call option to redeem outstanding Genentech shares; company to remain independent

Structural Bioinformatics and DuPont announce strategic alliance

U. of Alberta designs new bis-benzimidazole anticancer agents

Study indicates potential of KRN-5500 in the treatment of leukemia and lymphoma

Repligen acquires additional capital for secretin trials in autism

Kissei presents binding profile and functional characterization of alpha1-adrenoceptor antagonist

Relenza receives approval in the E.U. for treatment of influenza

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...